JavaScript is disabled for your browser. Some features of this site may not work without it.
Statistics
Total Visits
| Views | |
|---|---|
| Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature | 46 |
Total Visits Per Month
| March 2023 | April 2023 | May 2023 | June 2023 | July 2023 | August 2023 | September 2023 | |
|---|---|---|---|---|---|---|---|
| Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature | 12 | 16 | 6 | 5 | 2 | 3 | 2 |
File Visits
| Views | |
|---|---|
| Grau_erait_comp.pdf | 34 |
Top country views
| Views | |
|---|---|
| United States | 16 |
| Germany | 7 |
| Spain | 7 |
| South Korea | 2 |
| Turkey | 2 |
| Ecuador | 1 |
| France | 1 |
| Ireland | 1 |
| Israel | 1 |
| Iran | 1 |
Top cities views
| Views | |
|---|---|
| San Ramon | 5 |
| Barcelona | 4 |
| Redwood City | 2 |
| Valencia | 2 |
| Ala | 1 |
| Amstelveen | 1 |
| Ann Arbor | 1 |
| Ashburn | 1 |
| Durham | 1 |
| Lima | 1 |
